Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial

              Author:Pittock, Sean   Barnett, Michael   Bennett, Jeffrey   Berthele, Achim   De Seze, Jerome   Levy, Michael   Nakashima, Ichiro   Oreja Guevara, Celia   Palace, Jacqueline   Paul, Friedemann   Pozzilli, Carlo   Allen, Kerstin   Parks, Becky   Kim, Ho Jin   

              Session Name:S38: NMOSD, MOGAD, Demyelinating, and Other  

              Topic:Autoimmune Neurology  

              Program Number:S38.007  

              Author Institution:Mayo Clinic, Rochester, MN  University of Sydney, Sydney, Australia  University of Colorado, Aurora, CO  School of Medicine, Technical University of Munich, Muenchen, Germany  Strasbourg University Hospital Center, Starbourg, France  Massachusetts General Hospital and Harvard Medical School, Boston, MA  Tohoku Medical and Pharmaceutical University, Sendai, Japan  San Carlos Clinical Hospital and Complutense University of Madrid, Madrid, Spain  John Radcliffe Hospital, Oxford, United Kingdom  Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany  sapienza university, Rome, Italy  Alexion, AstraZeneca Rare Disease, Boston, MA  National Cancer Center, Goyang, Korea, Republic of  

              Oral Cladribine Capsules for Generalized Myasthenia Gravis: Design of the Actively Recruiting Phase 3 MyClad Study

              Author:Rejdak, Konrad   Howard Jr., James F.   Cutter, Gary   O'Connor, Kevin   Dimachkie, Mazen   Palace, Jacqueline   Meisel, Andreas   Mantegazza, Renato   Nolting, Axel   Gopalakrishnan, Sathej   Le Bolay, Claire   Javor, Andrija   Alexandri, Nektaria   Jack, Dominic   Kaminski, Henry   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.013  

              Author Institution:Medical University of Lublin, Lublin, Poland  University of Alabama at Birmingham, Birmingham, AL  Yale School of Medicine, Yale University , New Haven, CT  University of Kansas Medical Center, Kansas City, KS  University of Oxford, Oxford, United Kingdom  Charité – Universitätsmedizin Berlin, Berlin, Germany  IRCCS Carlo Besta, Milan, Italy  The healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  Merck Santé S.A.S., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Lyon, France  Ares Trading SA, an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland  Merck Serono Ltd., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Middlesex, United Kingdom  School of Medicine and Health Sciences, George Washington University, Washington, DC